Broad spectrum efficacy with LY2969822, an oral prodrug of metabotropic glutamate 2/3 receptor agonist LY2934747, in rodent pain models

BACKGROUND AND PURPOSE: A body of evidence suggests activation of metabotropic glutamate 2/3 (mGlu(2/3)) receptors would be an effective analgesic in chronic pain conditions. Thus, the analgesic properties of a novel mGlu(2/3) receptor agonist prodrug were investigated. EXPERIMENTAL APPROACH: After...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Pharmacol
Main Authors: Johnson, Michael P, Muhlhauser, Mark A, Nisenbaum, Eric S, Simmons, Rosa M A, Forster, Beth M, Knopp, Kelly L, Yang, Lijuan, Morrow, Denise, Li, Dominic L, Kennedy, Jeffrey D, Swanson, Steven, Monn, James A
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2017
Assuntos:
Research Papers
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5386998/
https://ncbi.nlm.nih.gov/pubmed/28177520
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.13740
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados